Ann Reed Gaines

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
    A R Gaines
    Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville Pike, Rockville, MD 20852, USA
    Blood 95:2523-9. 2000
  2. ncbi request reprint Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura
    Ann Reed Gaines
    Division of Biostatistics and Epidemiology HFM 220, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    Blood 106:1532-7. 2005
  3. pmc Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model
    Ann Reed Gaines
    Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA
    Transfusion 49:1050-8. 2009

Detail Information

Publications3

  1. ncbi request reprint Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
    A R Gaines
    Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville Pike, Rockville, MD 20852, USA
    Blood 95:2523-9. 2000
    ..Blood. 2000;95:2523-2529)..
  2. ncbi request reprint Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura
    Ann Reed Gaines
    Division of Biostatistics and Epidemiology HFM 220, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    Blood 106:1532-7. 2005
    ..Increased awareness of DIC as a diagnostic possibility may enable prompt recognition and medical intervention in affected patients...
  3. pmc Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model
    Ann Reed Gaines
    Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA
    Transfusion 49:1050-8. 2009
    ....